https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / Int. J. Cancer 2008 Aug;123(3):493-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / Int. J. Cancer 2008 Aug;123(3):493-92008-08-01 00:00:002019-02-15 09:22:02Oncolytic virotherapy as a personalized cancer vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / G Ital Dermatol Venereol 2008 Aug;143(4):235-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / G Ital Dermatol Venereol 2008 Aug;143(4):235-502008-08-01 00:00:002019-02-15 08:49:31Dendritic cell vaccines in metastasized malignant melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / Int J Hyperthermia 2008 Aug;24(5):399-408
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / Int J Hyperthermia 2008 Aug;24(5):399-4082008-08-01 00:00:002008-08-01 00:00:00Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: evaluation of two annular-phased-array applicators
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / J Biomech Eng 2008 Aug;130(4):041016
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / J Biomech Eng 2008 Aug;130(4):0410162008-08-01 00:00:002019-02-15 10:00:35A two-state cell damage model under hyperthermic conditions: theory and in vitro experiments
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / Clin. Cancer Res. 2008 Aug;14(15):4850-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / Clin. Cancer Res. 2008 Aug;14(15):4850-82008-08-01 00:00:002008-08-01 00:00:00A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-07-29 / Cancer Immunol. Immunother. 2008 Nov;57(11):1705-10
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-07-29 / Cancer Immunol. Immunother. 2008 Nov;57(11):1705-102008-07-29 00:00:002019-02-15 08:37:25Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-07-22 / Zhonghua Yi Xue Za Zhi 2008 Jul;88(28):1956-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-07-22 / Zhonghua Yi Xue Za Zhi 2008 Jul;88(28):1956-602008-07-22 00:00:002019-02-15 09:23:40[Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-07-15 / Cancer Res. 2008 Jul;68(14):5955-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-07-15 / Cancer Res. 2008 Jul;68(14):5955-642008-07-15 00:00:002019-02-15 08:46:49Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-07-11 / Cancer Immunol. Immunother. 2009 Mar;58(3):361-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-07-11 / Cancer Immunol. Immunother. 2009 Mar;58(3):361-712008-07-11 00:00:002008-07-11 00:00:00TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-07-11 / Lung Cancer 2009 Feb;63(2):247-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-07-11 / Lung Cancer 2009 Feb;63(2):247-502008-07-11 00:00:002019-02-15 08:34:58Inoperable Pancoast tumors treated with hyperthermia-inclusive multimodality therapies
